A retrospective study including 184 HBeAg-negative patients with detectable HBV DNA and normal ALT evaluated the predictive accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR) for significant fibrosis and cirrhosis. This evidence concerns the gene GPT and Cirrhosis.